20 May 2020: Legal guidance for mental health, learning disability and autism has been issued concerning the impact of the Covid-19 outbreak on the use of the Mental Health Act (MHA) and supporting systems to safeguard the legal rights of people receiving mental health, learning disability and autism services, including specialised commissioned services. It includes additional sections on the use of the Mental Health Act code of practice during the pandemic period, escorting patients detained under the Mental Health Act, and on the use of digital technology to support remote Mental Health Act assessments. It will be regularly updated to reflect the rapidly changing context and questions/concerns as well as feedback from the sector.
7 May 2020: Additional guidance covering monitoring aspects of oral antipsychotic drugs and ADHD during the Covid-19 outbreak has been released. The documents on antipsychotics and ADHD can be accessed via the North Central London (NCL) Joint Formulary Committee (JFC) website.
The NCL document Guidance on the Management of Drugs Requiring Monitoring during Covid-19, hosted on the NCL Covid-19 website, has also been refreshed to include links to the above guidelines.
25 March 2020: Islington GP Federation and Camden and Islington Mental Health Trust have put Serious Mental Illness (SMI) nurse clinics on hold as the nurses involved have returned to help colleagues at C&I to ensure the smooth delivery of essential care.
The Healthy London Partnership (HLP) has developed a range of materials designed to support GPs if they suspect someone may be experiencing a first episode of psychosis. Download the materials from the HLP website.